pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: phase readout×type: pdufa×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06385379: Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)

    Sponsor: Hangzhou Endonom Medtech Co., Ltd.. Phase: NA. Conditions: Aortic Arch Aneurysm

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06528080: A Clinical Study for the Treatment of Pediatric and Adolescent Patients With Type 1 Gaucher Disease

    Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: EARLY_PHASE1. Conditions: Gaucher Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07542379: The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer

    Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd.. Phase: EARLY_PHASE1. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06295796: A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Renal Impairment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07466862: Personalized Cooking and Nutrition Guidance and Physical Activities Program to Reduce Muscle Loss in Advanced Cancer

    Sponsor: Gali Perel. Phase: NA. Conditions: Cancer, Sarcopenia, Muscle Mass Loss

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06446427: The Effect of Acute High Altitude Exposure on Rescuer Performance and Patient Care

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: High Altitude, Hypobaric Hypoxia, Risk Reduction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05275686: Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)

    Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: Eustachian Tube Dysfunction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05380570: Epidemiological Study of Korean Radiation Workers

    Sponsor: Korea Institute of Radiological & Medical Sciences. Phase: . Conditions: Occupational Exposure to Radiation, Neoplasms, Radiation-Induced, Leukemia, Radiation-Induced, Radiation Effects

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07496970: Bilateral Cervical Plexus Block for Postoperative Pain After Thyroidectomy

    Sponsor: University of Gaziantep. Phase: NA. Conditions: Postoperative Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06884670: Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study

    Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: PHASE2. Conditions: Rectal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07015970: Real-life Follow-up of the Physical Activity in Type 1 Diabetes Participants Equipped With an Insulin Pump With Hybrid Closed Loop

    Sponsor: ISIS Diabete Service. Phase: . Conditions: Diabetes Mellitus Type 1, Glucose Metabolism Disorder, Glycemic Control for Diabetes Mellitus, Fear of Hypoglycemia, Treatment Satisfaction, Quality of Life, Hypoglycaemia

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT04243473: Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer

    Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: . Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07550673: Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis(UPRISE)

    Sponsor: Xijing Hospital of Digestive Diseases. Phase: PHASE4. Conditions: Acute Severe Ulcerative Colitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07355673: The Influence of Isolation Techniques in Gingival Irritation During an In-office Bleaching

    Sponsor: University of Santiago de Compostela. Phase: NA. Conditions: Gingival Irritation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07608341: Influence of Probiotics on Early Gut Microbial Colonization

    Sponsor: BioGaia AB. Phase: NA. Conditions: C-Section

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05234554: The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis

    Sponsor: Aldeyra Therapeutics, Inc.. Phase: PHASE3. Conditions: Allergic Conjunctivitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02771405: Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC

    Sponsor: National Hepatology & Tropical Medicine Research Institute. Phase: PHASE3. Conditions: Hepatitis C, Chronic, Hepatocellular Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04291859: Lu AF28996 in Participants With Parkinson's Disease (PD)

    Sponsor: H. Lundbeck A/S. Phase: PHASE1. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06951880: A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07483827: A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

    Sponsor: eleva GmbH. Phase: PHASE1. Conditions: C3 Glomerulopathy (C3G), Healthy Adult Participants

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06888427: Sleep Longitudinal Exploration of the Experience of Patients

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: . Conditions: Sleep

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04641442: Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02642042: Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: KRAS Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07370870: Is Cryotherapy Beneficial After Surgical Removal of Impacted Lower Third Molars?

    Sponsor: Henrique Tedesco. Phase: NA. Conditions: Cold Therapy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03265262: The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy

    Sponsor: Assistance Publique Hopitaux De Marseille. Phase: NA. Conditions: FOOD ALLERGY

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06572046: STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies

    Sponsor: IRCCS Fondazione Stella Maris. Phase: . Conditions: Hereditary Spastic Paraplegia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07368946: Phosphate Assessment in Chronic Kidney Disease Patients Study

    Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease Mineral and Bone Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07343427: Impact of GON PRF on Central Sensitization in Migraine Patients

    Sponsor: Ankara City Hospital Bilkent. Phase: NA. Conditions: Migraine, Central Sensitization

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06150027: Efficacy of a Systematic Referral to Palliative Care of Patients Who Need for Palliative Care During an Unscheduled Visit in Comprehensive Anticancer Centers

    Sponsor: Centre Leon Berard. Phase: NA. Conditions: Cancer, Emergencies

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05043870: Combined Immunosuppression for Pediatric Crohn's Disease

    Sponsor: Children's Hospital of Fudan University. Phase: PHASE4. Conditions: Crohn Disease, Infliximab, Immunosuppression, Children, Only

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07573670: A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia

    Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Newly Diagnosed Mixed Phenotype Acute Leukemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07607470: Large Algorithm Setting and Validation Study

    Sponsor: Nanopath, Inc. Phase: . Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, Vaginitis, Vaginal Diseases, Genital Diseases, Female, Female Urogenital Diseases, Urogenital Disease, Candidiasis, Mycoses, Vulvovaginitis, Vulvar Diseases, Vaginosis, Bacterial

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07030673: Early Discontinuation of Antibiotic Therapy in Elderly Patients Hospitalized for a Viral Infection

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Elderly, Antibiotics Overuse, Viral Infections, PCR Multiplex

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04232969: Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease

    Sponsor: University College, London. Phase: PHASE3. Conditions: Parkinson's Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06748469: Efficacy of Pulse Radiofrequency Durations in Lumbosacral Pain

    Sponsor: Ankara City Hospital Bilkent. Phase: . Conditions: RADICULAR PAIN

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07367269: Effect of Mandala Coloring on Anxiety, Distress, and Comfort in Breast Cancer Patients Receiving Outpatient Chemotherapy

    Sponsor: Artvin Coruh University. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07209683: The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults

    Sponsor: University of Oklahoma. Phase: NA. Conditions: Cognition, Neurovascular Coupling Mechanism and Cognitive Function, Neurovascular Control, Brain Aging, Brain Activity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07578454: VRehab-SMA Phase 1.2

    Sponsor: University of Oxford. Phase: NA. Conditions: Spinal Muscular Atrophy (SMA)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05338905: Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial

    Sponsor: Roswell Park Cancer Institute. Phase: NA. Conditions: Head and Neck Squamous Cell Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02313194: Spinal Cord Neuromodulation for Spinal Cord Injury

    Sponsor: University of California, Los Angeles. Phase: PHASE1. Conditions: Cervical Spinal Cord Injury, Tetraparesis, Tetraplegia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07323056: Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer

    Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: PHASE2. Conditions: EGFR-mutant Non-small Cell Lung Cancer, Potentially Resectable

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04703322: A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

    Sponsor: Daiichi Sankyo Co., Ltd.. Phase: PHASE2. Conditions: Tenosynovial Giant Cell Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07597122: MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Sepsis and Septic Shock

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06731322: Gut, Inflammation and Nutrition in Adult Patients After Fontan Operation

    Sponsor: University Medical Centre Ljubljana. Phase: . Conditions: Fontan Circulation, Fontan Procedure

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04188522: Imaging Post-Stroke Recovery: Using MEG to Evaluate Cognition

    Sponsor: Johns Hopkins University. Phase: . Conditions: Stroke, Stroke Sequelae, Stroke/Brain Attack

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06893731: Healthcare Utilization and Costs Among Hospitalized Patients With Cardiomyopathy

    Sponsor: China National Center for Cardiovascular Diseases. Phase: . Conditions: Cardiomyopathies, Cost

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04474431: Correlation of VEGF-A and Fluid Balance in Septic Shock

    Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Septic Shock

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06677931: Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Melasma

    Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: Melasma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06789731: Mindfulness-Based Interventions Targeting First-Generation College Student Retention in Rural Environments

    Sponsor: University of South Dakota. Phase: NA. Conditions: Depression, Anxiety

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03428802: Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

    Sponsor: Rutgers, The State University of New Jersey. Phase: PHASE2. Conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Neoplasm, Metastatic Malignant Solid Neoplasm, POLD1 Gene Mutation, POLE Gene Mutation, Recurrent Malignant Solid Neoplasm, Recurrent Ovarian Carcinoma, Stage III Breast Cancer AJCC v7, Stage III Ovarian Cancer AJCC v8, Stage IIIA Breast Cancer AJCC v7, Stage IIIA Ovarian Cancer AJCC v8, Stage IIIB Breast Cancer AJCC v7, Stage IIIB Ovarian Cancer AJCC v8, Stage IIIC Breast Cancer AJCC v7, Stage IIIC Ovarian Cancer AJCC v8, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8

    full page →ctgov ↗
    ← prev
    page 69 of 104
    next →